HALO AP® 2.4 Features and Functionalities
Check-out exciting new features and functionalities in the latest release of HALO AP®, AI-powered digital pathology platform for diagnostics
HALO AP® 2.4 Features and Functionalities Read More »
HALO AP
Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems
Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems
Migrating from Aperio eSlide Manager to Indica Labs HALO Image Management Systems Read More »
ECDP 2025
26 – 28 June 2025 | Visit us at booth #19 for a live demonstration of the latest developments across our HALO clinical and life science products on June 26-28 or prebook a meeting at our booth.
Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI
Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI
Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
Indica Labs’ Boston HALO® User Group Meeting
15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.
Indica Labs’ Boston HALO® User Group Meeting Read More »
Open Pathology and AI Integrations: Empowering Labs with Choice
In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.
Open Pathology and AI Integrations: Empowering Labs with Choice Read More »
CRC Macrodissect AI and Breast HER2 AI Sneak Peek
27 March 2025 | Learn about the latest advancements in AI-powered pathology. In this webinar, we’ll introduce CRC Macrodissect AI, an advanced solution designed to assist in colorectal cancer tumor content scoring and selecting regions for downstream macrodissection.
CRC Macrodissect AI and Breast HER2 AI Sneak Peek Read More »
Versant Diagnostics Selects HALO AP® Platform to Deploy Digital Pathology Across a Network of Laboratories
Albuquerque, NM and Grapevine, TX, February 4, 2025 – Indica Labs, the global leader of AI-powered digital pathology and Versant Diagnostics, an independent physician services company and proponent of next-generation digital pathology, announce today that Versant Diagnostics has chosen the HALO AP® platform from Indica Labs to further support their mission of helping world leading pathologists transition from conventional pathology to cutting edge digital technology.
Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform
Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.